Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-002949-40Phase 4Completed
Phase 4, randomised, double-blind trial in asthma comparing Seretide Diskus with Flixotide Diskus (2 arms). Primary endpoint: Mean morning peak expiratory flow over 12 weeks. Started Sep 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-002949-40.